Connect with us

News

WuXi AppTec
Expansion in California for Pharmaceutical R&D Services

Published

on


News, Pharmaceuticals

WuXi AppTec, a pharmaceutical and medical device open-access capability and technology platform company with global operations, announces the expansion of its facilities in San Diego, California.

WuXi AppTec’s newly expanded facility will establish a center of excellence in screening, discovery biology, pharmacology, and small molecule process R&D including phase I GMP manufacturing. The expansion will provide key elements of WuXi’s small molecule capability and technology platform under one roof, further enhancing services to North American pharmaceutical and biotech industries. WuXi will also add extensively from the local talent base, further contributing to regional economic growth.

“The San Diego life science community continues to thrive with the commitments and investments made by leading international powerhouses like WuXi AppTec,” said Joe Panetta, president and CEO of Biocom. “Their latest facility expansion in San Diego is a testament to the deep relationships they have built with the local biotech community. Biocom applauds the positive impact they’ve had on the region’s economic growth and innovative healthcare products for our patients.”

“This expansion will enable us to better serve our U.S. and global customers, and contribute to the growth and success of the dynamic San Diego biotech ecosystem. Together with our ecosystem partners, we will continue to strengthen WuXi’s capability and technology enabling platform to expedite the discovery and development of new medicines for patients worldwide, and for a future where every drug can be made and every disease can be treated.”

Dr. Ge Li, Chairman and CEO of WuXi AppTec

Food & Beverage News

Agriculture business
G&G partners with Camellia GroupPicture

Published

on

Green & Gold Macadamias (G&G) and AIM listed Camellia Group Plc
Picture: Green & Gold Macadamias and AIM listed Camellia Group Plc

Green & Gold Macadamias (G&G) and AIM listed Camellia Group Plc announced their strategic macadamia marketing partnership. This adds to G&G’s extensive processor and producer partner network in key growing territories including Australia, South Africa, Kenya, Malawi and Brazil. Both organisations take a long view of the macadamia market: continued growth in supply, together with changing consumer demands, means planning for the future central to philosophy.

“We are delighted that Camellia has taken the decision to market their macadamia brand, Maclands through G&G. The addition of their produce now makes us responsible for selling 20% of the globe’s kernel crop in all markets around the world. Quality predicates who we do business with, and Camellia represents a trusted partner in this regard. Guaranteed increase in quality supply creates the opportunity to scale vertically into new product markets and horizontally into new geographies.”

Brian Loader, CEO, G&G

A unique aspect to this sector is the parallel rise of both supply and demand for product. Consumer trends around plant based and healthy eating are growing: and they are here to stay. Additionally, today’s customer is discerning and sensitive to sustainable, ethical and traceable food production. Global supply of macadamias has increased over 50% in the last 5 years to 210,000 tonnes in-shell. According to the International Nut Council, the crop is projected to double again by 2023. G&G’s focus is to innovate in how and where this future supply is absorbed into market.

Macadamias, currently predominantly consumed as a snack, hold a premium perception. Prospectively G&G is carving the way for new products in a variety of sweet and savoury foods like butters, milks, cheese and yoghurts to biscuits and ice cream, amongst others. Unilever’s Magnum ice cream brand has recently launched a macadamia ice cream in Australia, Indonesia and Thailand, using G&G’s macadamias. Investment into infrastructure to support these future market changes is ongoing. The nut’s oil is also of interest to the food, cosmetic and health industry.

“G&G is specialist in what they do: a highly professional macadamia marketing company with a large network of reputable producers and an established, strategic customer base, in a variety of segments around the globe. The organisation also has cultivated longstanding direct relationships key customers and leading retailers. This market diversification, together with our aligned vision for value add and vertical integration, places G&G in a strong marketing position for years to come. This partnership allows us to be well placed to market our growth in product over the next ten years.” says Graham Mclean, Managing Director of Agriculture, Camellia.

Camellia has long-standing macadamia operations that started in Malawi in the 1980’s. Over the years the Group has invested in orchard growth and processing infrastructure. Its reach extends, in varying stages of maturity, across 1400 hectares in Malawi, 1100 hectares in South Africa and currently 1000 hectares in Kenya, with plans to increase Kenyan orchards to 1500 hectares over the next ten years. This makes Camellia one of the world’s largest macadamia producers.

Continue Reading

News Water & Waste Water

Lonza
Divestment of Water Care Business

Published

on

Lonza announced the completion of the divestment of its former Water Care business and operations to Platinum Equity for USD 630 million. The strategic agreement between both parties was already announced on 1 November 2018.

The company plans to re-invest parts of the proceeds of the Water Care disposal into the Healthcare Continuum and will continue to focus on deleveraging as has already been communicated. Earlier Lonza also announced the internal alignment of its business structure and a new Executive Committee member to further strengthen the company’s position along the Healthcare Continuum.

Continue Reading

News

Group increases sales, earnings and employment
Growth spurt for Endress+Hauser

Published

on

Headquarters of the Endress+Hauser Group in Reinach, Switzerland.
Headquarters of the Endress+Hauser Group in Reinach, Switzerland. (Picture: Endress+Hauser)

Endress+Hauser’s business developed very positively across all regions and industries in 2018. The Group, one of the world’s leading providers of process and laboratory instrumentation, automation solutions and services, reports new highs in net sales, income and employment.

According to preliminary figures, the company increased net sales by more than 9 percent to over 2.4 billion euros in 2018. Exchange rate effects prevented even better results. “In local currencies, we grew nearly 13 percent,” said Chief Financial Officer Dr Luc Schultheiss. The family-owned company created new jobs primarily in production, research and development and services. At the end of 2018, Endress+Hauser had 13,928 employees worldwide, 629 more than the year before.

“The solid development in sales shows that we have held our ground well in the market. We supported our customers with more than 50 new products, solutions and services. We were able to break new ground through our digitalization strategy, as well as in the measurement and analysis of quality-relevant parameters.”

Matthias Altendorf, CEO Endress+Hauser

Good start to the new year

The company is expecting a somewhat weaker market dynamic for the current year. The Group is anticipating growth in the mid single-digit range, with earnings remaining at a healthy level. “The year has gotten off to a good start so far,” reported Luc Schultheiss. Assuming the business remains well on track, the Group expects to create several hundred new jobs around the world.

Endress+Hauser will present its 2018 audited financial figures on 14 May 2019 in Basel, Switzerland.

Continue Reading